Skip to main content
S3V Vascular Technologies Limited

S3V Vascular Technologies Limited

Offers Price : ₹445.00

About S3V Vascular Technologies Limited

S3V Vascular Technologies Limited, founded in 2011 and headquartered in Mysore, Karnataka, is a medical device manufacturer focused on advanced cardiovascular and critical-care products, operating through a fully integrated model that combines in-house research and development, proprietary technology and regulated manufacturing facilities. It became the first company to receive a manufacturing license for an expandable titanium-based intervertebral body fusion device (expandable spinal cage), with the first successful implant performed in Pune, and is currently the only manufacturer globally offering this specific expandable cage. Its product portfolio includes drug-eluting and bare-metal stents, PTCA and neurovascular catheters, esophageal and biliary stents, and India’s first indigenous mechanical thrombectomy device for stroke treatment, aiming to reduce import dependence and improve affordability in a market largely dominated by imported devices. Led by promoter Badari Narayan, a m...

Fundamentals
S3V Vascular Technologies Limited Price445.00 Per Equity Share
Lot Size500 Shares
52 Week High445 Shares
52 Week Low350 Shares
DepositoryNSDL & CDSL
PAN NumberAAQCS2303F
ISIN NumberINE0HGT01012
CINU33112KA2011PLC059915
RTAAarthi Consultants
Market Cap (in Cr.)853.00
P/E Ratio0.00
P/B Ratio5.65
D/E Ratio0.18
ROE-2.26
Book Value78.82
Face Value10.00
Total Shares19178590

Financials (Figures in ₹ Cr)

P&L Statement
Field202220232024
da1.51.72.07
eps2.080.42-1.66
npm12.862.95-21.27
opm27.6219.4716.67
pat2.70.56-3.19
pbt2.80.65-3.06
tax0.10.090.13
ebit4.320.43
ebitda5.83.72.5
revenue211915
pbt margins13.333.42-20.4
ebit margins20.4810.532.87
finance cost1.41.33.5
other income0.090.080.2
gross margins63.3358.4263.33
other expenses5.54.84
change in inventory1.1-0.60.8
cost of material consumed6.68.54.7
employee benefit expenses22.63

Shareholding Pattern

Events

Name
S3V's Allotment of CCPS of ₹8.45 Cr corporate_action Allotment of 4,80,123 Non-Cumulative Compulsorily Convertible Preference Shares (CCPS) on a preferential basis. (26/03/2024)
S3V's Allotment of CCPS of ₹89.92 Cr corporate_action Allotment of 51,09,183 CCPS @176/share on a preferential basis. (13/03/2024)

Promoters or Management

NameDesignationExp.
Badari NarayanMD & CEO25+LinkedIn
Vijaya Gopal NagaradagaddeDirector, Co-founder15+LinkedIn